Viral Hepatitis Among Drug Users in Methadone Maintenance: Associated Factors, Vaccination Outcomes, and Interventions
Year: 2014
Type: article
Abstract: Drug users are at high risk of viral Hepatitis A, B, and C. The prevalence of Hepatitis A, Hepatitis B, and Hepatitis C, associated factors, and vaccine seroconversion among drug treatment program participants in a randomized controlled trial of hepatitis care coordination were examined. Of 489 participants, 44 and 47% required Hepatitis A/Hepatitis B vaccinations, respectively; 59% were Hepatitis C positive requiring linkage to care. Factors associated with serologic statuses, and vaccine seroconversion are reported; implications for strategies in drug treatment settings are discussed. Results suggest generalizable strategies for drug treatment programs to expand viral hepatitis screening, prevention, vaccination, and linkage to care.
Source: Journal of Addictive Diseases
Authors: David C. Perlman, Ashly E. Jordan, Courtney McKnight, Christopher Young, Kevin L. Delucchi, James L. Sorensen, Don C. Des Jarlais, Carmen L. Masson
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institute on Drug Abuse
Awards: Hepatitis Care Coordination in Methadone Treatment, Western States Node of the National Drug Abuse Treatment Clinical Trials Network, Treatment for Complex Patients: Continuing and Extended Care, Hepatitis Care Coordination in Methadone Treatment, Reinvigorating HIV Prevention and Care for People Who Use Drugs: Accelerating Progress and Sustaining Gains in the Midst of Societal Disruption, Western States Node of the National Drug Abuse Treatment Clinical Trials Network
OpenAlex ID: W1968459990